Triclosan: environmental exposure, toxicity and mechanisms of action
Tóm tắt
Triclosan [5‐chloro‐2‐(2,4‐dichlorophenoxy)phenol; TCS] is a broad spectrum antibacterial agent used in personal care, veterinary, industrial and household products. TCS is commonly detected in aquatic ecosystems, as it is only partially removed during the wastewater treatment process. Sorption, biodegradation and photolytic degradation mitigate the availability of TCS to aquatic biota; however the by‐products such as methyltriclosan and other chlorinated phenols may be more resistant to degradation and have higher toxicity than the parent compound. The continuous exposure of aquatic organisms to TCS, coupled with its bioaccumulation potential, have led to detectable levels of the antimicrobial in a number of aquatic species. TCS has been also detected in breast milk, urine and plasma, with levels of TCS in the blood correlating with consumer use patterns of the antimicrobial. Mammalian systemic toxicity studies indicate that TCS is neither acutely toxic, mutagenic, carcinogenic, nor a developmental toxicant. Recently, however, concern has been raised over TCS's potential for endocrine disruption, as the antimicrobial has been shown to disrupt thyroid hormone homeostasis and possibly the reproductive axis. Moreover, there is strong evidence that aquatic species such as algae, invertebrates and certain types of fish are much more sensitive to TCS than mammals. TCS is highly toxic to algae and exerts reproductive and developmental effects in some fish. The potential for endocrine disruption and antibiotic cross‐resistance highlights the importance of the judicious use of TCS, whereby the use of TCS should be limited to applications where it has been shown to be effective. Copyright © 2011 John Wiley & Sons, Ltd.
Từ khóa
Tài liệu tham khảo
Boehmer W, 2004, Retrospective monitoring of Triclosan and methyl‐triclosan in fish: results from the German environmental specimen bank, Organohalogen Compd., 66, 1516
CIBA 1998.Brochure no. 2521: IRGASAN DP 300/IRGA‐CARE MP: Toxicological and ecological data/Official registration.
DeSalva SJ, 1989, Triclosan: a safety profile, Am. J. Dent., 2, 185
FahrigR.1978.The effects of Irgasan DP 300 in the “Mammalian Spot Test” anin vivomethod for the detection of genetic alterations in somatic cells of mice. June 22. Zentrallaboratorium fur mutagenate‐sprufung der Deutschan Forschungs‐geneinshaf.
Imazato S, 1995, Antibacterial effect of composite incorporating triclosan against Streptococcus mutans, J. Osaka Univ. Dent. Sch., 35, 5
Jirasripongpun K, 2008, Risk assessment of triclosan using animal cell lines, Kasetsart J. (Nat. Sci.), 42, 353
Lee HB, 2002, Organic contaminants in Canadian municipal sewage sludge. Part I. Toxic or endocrine‐disrupting phenolic compounds, Water Qual. Res. J. Can., 37, 681, 10.2166/wqrj.2002.046
Lin YJ, 2000, Buccal absorption of triclosan following topical mouthrinse application, Am. J. Dent., 13, 215
Lyman FL, 1969, Toxicology of 2,4,4′‐Trichloro‐2′‐hydroxy‐diphenyl ether, Industr. Med. Surg., 38, 45
Nassef M, 2009, Pharmaceuticals and personal care products toxicity to Japanese medaka fish (Oryzias latipes), J. Fac. Agric. Kyushu Univ., 54, 407, 10.5109/16123
Norris DO, 2006, Endocrine Disruption: Biological Basis for Health Effects in Wildlife and Humans
Servos MR, 2007, The presence of selected pharmaceuticals and the antimicrobial triclosan in drinking water in Ontario, Canada, Water Qual. Res. J. Can., 42, 130, 10.2166/wqrj.2007.016
Siddiqui WH, 1979, Pharmacokinetics of triclosan in rat after intravenous and intravaginal administration, J. Environ. Pathol. Toxicol., 2, 861
Swedish Chemical Agency.2001.Iniative against antibacterial additives in consumer products. Available from:http://www.kemi.se/upload/Trycksaker/Pdf/Antibaktrapport_2001.pdf
Tatarazako N, 2004, Effects of triclosan on various aquatic organisms, Environ. Sci., 11, 133
Broek AMWT, 2008, A review of the current literature on management of halitosis, Oral Dis., 14, 30, 10.1111/j.1601-0825.2006.01350.x